Accentuated hyperparathyroidism in type II Bartter syndrome

Daniel Landau, Evgenia Gurevich, Levana Sinai-Treiman, Hannah Shalev

    Research output: Contribution to journalArticlepeer-review

    11 Scopus citations


    Background: Bartter syndrome (BS) may be associated with different degrees of hypercalciuria, but marked parathyroid hormone (PTH) abnormalities have not been described. Methods: We compared clinical and laboratory data of patients with either ROMK-deficient type II BS (n = 14) or Barttin-deficient type IV BS (n = 20). Results: Only BS-IV patients remained mildly hypokalemic in spite of a higher need for potassium supplementation. Estimated glomerular filtration rate (eGFR) was mildly decreased in only four BS-IV patients. Average PTH values were significantly higher in BS-II (160.6 ± 85.8 vs. 92.5 ± 48 pg/ml in BS-IV, p = 0.006). In both groups, there was a positive correlation between age and log(PTH). Levels of 25(OH) vitamin D were not different. Total serum calcium was lower (within normal limits) and age-related serum phosphate (Pi)-SDS was increased in BS-II (1.19 ± 0.71 vs. 0.01 ± 1.04 in BS-IV, p < 0.001). The GFR threshold for Pi reabsorption was higher in BS-II (5.63 ± 1.25 vs. 4.36 ± 0.98, p = 0.002). Spot urine calcium/creatinine ratio and nephrocalcinosis rate (100 vs. 16 %) were higher in the BS-II group. Conclusions: PTH, serum Pi levels, and urinary threshold for Pi reabsorption are significantly elevated in type II vs. type IV BS, suggesting a PTH resistance state. This may be a response to more severe long-standing hypercalciuria, leading to a higher rate of nephrocalcinosis in BS-II.

    Original languageEnglish
    Pages (from-to)1085-1090
    Number of pages6
    JournalPediatric Nephrology
    Issue number7
    StatePublished - 1 Jul 2016


    • Bartter syndrome
    • Barttin
    • Hypercalciuria
    • Nephrocalcinosis
    • Parathyroid hormone
    • ROMK

    ASJC Scopus subject areas

    • Pediatrics, Perinatology, and Child Health
    • Nephrology


    Dive into the research topics of 'Accentuated hyperparathyroidism in type II Bartter syndrome'. Together they form a unique fingerprint.

    Cite this